Published in Med Microbiol Immunol on November 17, 1978
Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression. J Virol (2000) 1.00
Comparison of in vitro lymphocyte proliferations induced by cytomegalovirus-infected human fibroblasts and cell-free cytomegalovirus. Infect Immun (1980) 0.86
Mitogenic activity in human embryonic fibroblasts early after infection by human cytomegalovirus. Infect Immun (1982) 0.75
Cytomegalovirus (CMV): specific lymphokine production in congenital CMV infection. Clin Exp Immunol (1985) 0.75
Herpes simplex virus DNA. Virology (1968) 5.65
Proteins released from Mycobacterium tuberculosis during growth. Infect Immun (1991) 3.69
Inhibition of growth of Chlamydia trachomatis by human gamma interferon. Infect Immun (1985) 2.74
A technique for accessory cervical heart transplantation in rabbits and rats. Acta Pathol Microbiol Scand A (1971) 2.55
T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun (1991) 2.43
Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun (1993) 2.27
Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination. Lancet (1984) 2.16
Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J Biol Chem (1990) 2.12
Cytomegalovirus infection among renal allograft recipients. Acta Med Scand (1969) 2.11
Studies on the nature and location of the capsid polypeptides of vaccinia virions. Virology (1972) 2.11
Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol (1992) 2.05
Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor. Infect Immun (1988) 2.04
Deoxyribonucleic acid-dependent ribonucleic acid polymerase activity in purified trachoma elementary bodies: effect of sodium chloride on ribonucleic acid transcription. J Bacteriol (1971) 2.03
Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci U S A (1978) 1.98
Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. Infect Immun (1987) 1.96
The morphogenesis of human cytomegalovirus. Isolation and polypeptide characterization of cytomegalovirions and dense bodies. Virology (1975) 1.93
Trachoma agent DNA. J Mol Biol (1969) 1.76
Clinically evident, non-terminal infections with herpesviruses and the wart virus in immunosuppressed renal allograft recipients. Br Med J (1970) 1.74
Antibody responses against Mycobacterium tuberculosis in 11 strains of inbred mice: novel monoclonal antibody specificities generated by fusions, using spleens from BALB.B10 and CBA/J mice. Infect Immun (1988) 1.70
Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis. Infect Immun (1990) 1.66
Regulatory effect of interferon on T cells in vitro. J Immunol (1976) 1.62
Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet (1985) 1.54
Kinetics of specific immunoglobulins M, E, A, and G in congenital, primary, and secondary cytomegalovirus infection studied by antibody-capture enzyme-linked immunosorbent assay. J Clin Microbiol (1988) 1.52
A Single Solution Indicator for Anaerobiosis. J Bacteriol (1948) 1.49
Antibodies against cytomegalovirus-induced early antigens (CMV-EA) in immunosuppressed renal-allograft recipients. Clin Exp Immunol (1977) 1.49
Serum specific IgA antibody to Chlamydia trachomatis in patients with chlamydial infections detected by ELISA and an immunofluorescence test. J Clin Pathol (1984) 1.46
In vitro stimulation of human lymphocytes by purified cytomegalovirus. Intervirology (1977) 1.45
Studies on vaccinia virus DNA. Virology (1967) 1.44
Smooth-muscle antibodies and other tissue antibodies in cytomegalovirus infection. Clin Exp Immunol (1975) 1.44
Monoclonal antibodies produced in BALB.B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis. J Clin Microbiol (1988) 1.44
Focal necrotic hepatitis in mice as a biological marker for differentiation of Herpesvirus hominis type 1 and type 2. J Gen Virol (1974) 1.43
Antibiotics versus placebo for prevention of postoperative infection after appendectomy. Cochrane Database Syst Rev (2001) 1.41
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine (1999) 1.33
Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods (1993) 1.32
ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand (1986) 1.32
Medical expenditures of terminal cancer patients during the last year of life. Inquiry (1984) 1.31
Isolation and characterization of intermediates in vaccinia virus morphogenesis. Virology (1973) 1.30
Role of activated macrophages in resistance of congenitally athymic nude mice to hepatitis induced by herpes simplex virus type 2. Infect Immun (1978) 1.30
Antibiotics versus placebo for prevention of postoperative infection after appendicectomy. Cochrane Database Syst Rev (2005) 1.28
Reversion of the antichlamydial effect of tumor necrosis factor by tryptophan and antibodies to beta interferon. Infect Immun (1989) 1.28
Fate of Chlamydia trachomatis in human monocytes and monocyte-derived macrophages. Infect Immun (1986) 1.28
Isolation and polypeptide characterization of varicella-zoster virus. Virology (1980) 1.27
Recent advances in Chlamydia trachomatis. Eur J Epidemiol (1985) 1.26
Seminal fluid excretion of cytomegalovirus related to immunosuppression in homosexual men. Br Med J (Clin Res Ed) (1983) 1.26
Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus. Vaccine (1987) 1.25
A prospective study on the incidence and significance of congenital cytomegalovirus infection. Acta Paediatr Scand (1979) 1.24
The development of immunofluorescent antibodies as compared with complement-fixing and virus-neutralizing antibodies in human cytomegalovirus infection. Scand J Infect Dis (1972) 1.23
Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J Biol Stand (1987) 1.23
Characterization of intermediates in the uncoating of vaccinia virus DNA. Virology (1972) 1.22
Lifestyle and antiviral antibody studies among homosexual men in Denmark. Acta Pathol Microbiol Immunol Scand B (1983) 1.20
Electron microscopy of human cytomegalovirus DNA. Arch Virol (1976) 1.18
Detection of IgG antibodies specific for measles virus by enzyme-linked immunosorbent assay (ELISA). Intervirology (1979) 1.18
Serum amyloid A (SAA) in viral infection: rubella, measles and subacute sclerosing panencephalitis (SSPE). Clin Exp Immunol (1982) 1.16
Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis. Infect Immun (1992) 1.16
A rapid immunoperoxidase assay for the detection of specific IgG antibodies to Chlamydia trachomatis. J Clin Pathol (1983) 1.16
Studies on the differentiation of T lymphocytes in sheep. I. Recognition of a sheep T-lymphocyte differentiation antigen by a monoclonal antibody T-80. Immunology (1983) 1.14
RNA in the elementary bodies of trachoma agent. Nature (1968) 1.12
The migration of lymphocytes in the fetal lamb. Eur J Immunol (1979) 1.12
Immunity against diphtheria and tetanus in the age group 30-70 years. Scand J Infect Dis (1988) 1.11
Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies. Infect Immun (1977) 1.11
Serologic differentiation of human cytomegalovirus strains using rabbit hyperimmune sera. Brief report. Arch Gesamte Virusforsch (1971) 1.10
Cytomegalovirus neutralization by plaque reduction. Arch Gesamte Virusforsch (1971) 1.09
Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene (2006) 1.09
Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon. Infect Immun (1990) 1.07
Bordetella pertussis and chronic cough in adults. Clin Infect Dis (1999) 1.06
Rate of inactivation of cytomegalovirus in raw banked milk during storage at -20 degrees C and pasteurisation. Br Med J (Clin Res Ed) (1982) 1.05
The influence of complement on cytomegalovirus neutralization by antibodies. Arch Gesamte Virusforsch (1972) 1.05
Detecting Chlamydia trachomatis in men with urethritis: serology v isolation in cell culture. Genitourin Med (1989) 1.05
Antibodies to the Epstein-Barr virus in kidney transplant recipients. Acta Med Scand (1972) 1.04
Antigenic polypeptides of Israeli spotted fever isolates compared with other spotted fever group rickettsiae. Ann N Y Acad Sci (1990) 1.03
Detection of virus-specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection by enzymeimmuno and radioimmunoassay techniques. Clin Exp Immunol (1982) 1.02
Immunoperoxidase antibody to human cytomegalovirus-induced membrane antigen assay in the absence of interfering immunoglobulin G receptors. Intervirology (1980) 1.02
Specific IgG and IgA antibodies to Chlamydia trachomatis in infertile women. Int J Fertil (1986) 1.02
Effect of silica on the pathogenic distinction between herpes simplex virus type 1 and 2 hepatitis in mice. Infect Immun (1977) 1.01
Comparison between cell culture and serology for detecting Chlamydia trachomatis in women seeking abortion. J Clin Pathol (1988) 1.01
Antibodies to pigeon antigens in pigeon breeders. Detection of antibodies by an enzyme-linked immunosorbent assay. Eur J Respir Dis (1982) 1.01
The interaction between pertussis toxin and 10 monoclonal antibodies. Acta Pathol Microbiol Immunol Scand C (1987) 1.00
Detection of specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection. Intervirology (1981) 1.00
Herpesvirus hominis infections in renal transplant recipients. Scand J Infect Dis (1975) 1.00
Antibody patterns to herpesviruses in kaposi's sarcoma: serological association of european kaposi's sarcoma with cytomegalovirus. Int J Cancer (1975) 1.00
Determination of specific IGA antibodies to varicella zoster virus by immunoperoxidase assay. J Clin Pathol (1982) 1.00
Antibody to varicella-zoster virus-induced membrane antigen: immunoperoxidase assay with air-dried target cells. J Infect Dis (1979) 0.99
Inhibition of Chlamydia trachomatis replication in HEp-2 cells by human monocyte-derived macrophages. Infect Immun (1988) 0.99
Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin. J Infect Dis (1997) 0.99
Studies of human cytomegalovirus strain variations by kinetic neutralization tests. Arch Gesamte Virusforsch (1972) 0.98
Enzyme-linked immunosorbent assay (ELISA) for detection of herpes simplex virus-specific IgM antibodies. J Virol Methods (1982) 0.97
Measurement delay associated with the Guardian RT continuous glucose monitoring system. Diabet Med (2010) 0.97
Viral infections in renal allograft recipients treated with long-term immunosuppression. Br Med J (1979) 0.97
Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes. Cell Immunol (1982) 0.96
Lymphocyte recirculation in the sheep fetus. Ciba Found Symp (1980) 0.96
T-cell recirculation in the sheep: migratory properties of cells from lymph nodes. Immunology (1982) 0.96
Enzyme-linked immunosorbent assay for detection of virus-specific IgM antibodies to varicella-zoster virus. Intervirology (1980) 0.96
Affinity purification, biological characterization and serological evaluation of defined antigens from Mycobacterium tuberculosis. Trop Med Parasitol (1990) 0.96
The actions of interferon are potentiated at elevated temperature. Nature (1978) 0.96
Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. J Natl Cancer Inst (1988) 0.95
Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine (1997) 0.95
Tumor necrosis factor alpha and prostaglandin E2 production by human monocyte-derived macrophages infected with spotted fever group rickettsiae. Ann N Y Acad Sci (1990) 0.95
Studies on the specificity of the complement fixation test in cytomegalovirus infections. With special reference to possible cross-reactions with other herpesvirus antigens. Scand J Infect Dis (1971) 0.94